RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value: $969M (100.0% shares, 0.0% debt)

Holdings (30)

WVE WAVE LIFE SCIENCES PTE LTD 23.7%
Value $230M Shares 7,088,651 Share Price $32.47 * Est. Cost/Share $15.68 Unrealized @ Report Date +50.7%
— ACHILLION PHARMACEUTICALS INC 10.1%
Value $97.47M Shares 12,033,220 Share Price $8.10 Est. Cost/Share $6.45 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 7.6%
Value $74M Shares 3,681,491 Share Price $20.10 Est. Cost/Share $16.44 Unrealized @ Report Date —
— AVEXIS INC 7.4%
Value $71.39M Shares 1,732,274 Share Price $41.21 Est. Cost/Share $30.41 Unrealized @ Report Date —
— AXOVANT SCIENCES LTD 7.2%
Value $70M Shares 5,000,000 Share Price $14.00 Est. Cost/Share $20.38 Unrealized @ Report Date —
— NEKTAR THERAPEUTICS 6.5%
Value $62.95M Shares 3,664,154 Share Price $17.18 Est. Cost/Share $14.17 Unrealized @ Report Date —
ARDX ARDELYX INC 4.4%
Value $42.26M Shares 3,266,045 Share Price $12.94 * Est. Cost/Share $10.51 Unrealized @ Report Date -0.4%
ACRS ACLARIS THERAPEUTICS INC 4.1%
Value $39.62M Shares 1,547,152 Share Price $25.61 * Est. Cost/Share $19.34 Unrealized @ Report Date +9.7%
TGTX TG THERAPEUTICS INC 3.7%
Value $35.84M Shares 4,631,114 Share Price $7.74 * Est. Cost/Share $10.06 Unrealized @ Report Date -36.1%
— MERUS N V 3.2%
Value $31.45M Shares 2,656,166 Share Price $11.84 Est. Cost/Share $13.32 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 3.0%
Value $29.29M Shares 2,191,977 Share Price $13.36 Est. Cost/Share $13.67 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 2.0%
Value $19.39M Shares 1,292,940 Share Price $15.00 Est. Cost/Share $20.75 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 1.7%
Value $16.85M Shares 1,820,138 Share Price $9.26 Est. Cost/Share $9.26 Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 1.6%
Value $15.94M Shares 754,411 Share Price $21.13 * Est. Cost/Share $13.67 Unrealized @ Report Date 0.0%
— PROTEON THERAPEUTICS INC 1.6%
Value $15.18M Shares 1,626,931 Share Price $9.33 Est. Cost/Share $11.31 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 1.5%
Value $14.28M Shares 2,428,571 Share Price $5.88 Est. Cost/Share $28.25 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 1.4%
Value $13.19M Shares 2,989,795 Share Price $4.41 * Est. Cost/Share $9.58 Unrealized @ Report Date -58.3%
— STRONGBRIDGE BIOPHARMA PLC 1.3%
Value $13.06M Shares 2,501,667 Share Price $5.22 Est. Cost/Share $7.60 Unrealized @ Report Date —
— AUDENTES THERAPEUTICS INC 1.3%
Value $12.6M Shares 707,426 Share Price $17.81 Est. Cost/Share $17.81 Unrealized @ Report Date —
— DIMENSION THERAPEUTICS INC 1.3%
Value $12.37M Shares 1,548,033 Share Price $7.99 Est. Cost/Share $10.25 Unrealized @ Report Date —
— ACCELERON PHARMA INC 1.2%
Value $11.53M Shares 318,565 Share Price $36.19 Est. Cost/Share $36.19 Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS INC 1.2%
Value $11.21M Shares 1,525,424 Share Price $7.35 * Est. Cost/Share $6.48 Unrealized @ Report Date 0.0%
— TENAX THERAPEUTICS INC 0.6%
Value $5.532M Shares 2,389,700 Share Price $2.31 Est. Cost/Share $3.92 Unrealized @ Report Date —
ONC BEIGENE LTD 0.5%
Value $5.238M Shares 170,000 Share Price $30.81 Est. Cost/Share $29.31 Unrealized @ Report Date —
— ALCOBRA LTD 0.5%
Value $5.051M Shares 2,044,756 Share Price $2.47 Est. Cost/Share $6.39 Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 0.5%
Value $4.743M Shares 354,200 Share Price $13.39 Est. Cost/Share $16.17 Unrealized @ Report Date —
SGMO SANGAMO BIOSCIENCES INC 0.4%
Value $4.164M Shares 899,438 Share Price $4.63 * Est. Cost/Share $8.61 Unrealized @ Report Date -40.9%
— AEGLEA BIOTHERAPEUTICS INC 0.2%
Value $2.155M Shares 336,134 Share Price $6.41 Est. Cost/Share $4.86 Unrealized @ Report Date —
— ARCA BIOPHARMA INC 0.2%
Value $1.476M Shares 521,606 Share Price $2.83 Est. Cost/Share $4.96 Unrealized @ Report Date —
— AKARI THERAPEUTICS PLC 0.1%
Value $970K Shares 114,039 Share Price $8.51 Est. Cost/Share $24.00 Unrealized @ Report Date —